Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,039 | -56,241 | -35,836 | -16,934 | -48,607 |
| Depreciation Amortization | -4,960 | -6,215 | -4,654 | -2,195 | -2,818 |
| Accounts receivable | N/A | N/A | -90 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,275 | 834 | 1,249 | 1,417 | 2,012 |
| Other Working Capital | 2,906 | -1,990 | -5,392 | -8,397 | 3,439 |
| Other Operating Activity | 8,105 | 5,561 | 2,591 | 97 | 295 |
| Operating Cash Flow | $-78,713 | $-58,051 | $-42,132 | $-26,012 | $-45,679 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -300,530 | -311,644 | -343,648 | -307,432 | -121,195 |
| PPE Investments | -234 | -25 | -26 | -12 | 0 |
| Investing Cash Flow | $-300,764 | $-311,669 | $-343,674 | $-307,444 | $-121,195 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -365 | -365 | -365 | -365 | -16,291 |
| Common Stock Issued | 632,068 | 408,654 | 406,487 | 406,410 | 2,082 |
| Other Financing Activity | -3,424 | -3,424 | -3,424 | -3,387 | 101,206 |
| Financing Cash Flow | $628,279 | $404,865 | $402,698 | $402,658 | $86,997 |
| Beginning Cash Position | 8,266 | 8,266 | 8,266 | 8,266 | 88,143 |
| End Cash Position | 257,068 | 43,411 | 25,158 | 77,468 | 8,266 |
| Net Cash Flow | $248,802 | $35,145 | $16,892 | $69,202 | $-79,877 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,713 | -58,051 | -42,132 | -26,012 | -45,679 |
| Capital Expenditure | -234 | -25 | -26 | -12 | N/A |
| Free Cash Flow | -78,947 | -58,076 | -42,158 | -26,024 | -45,679 |